Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

February 28, 2009

Conditions
Acute Decompensated Heart Failure
Interventions
DRUG

Nesiritide

Bolus 2 mcg/kg followed by 0.01 mcg/kg/min

DRUG

Nitroglycerin

5-10 mcg/min titrating per protocol based on blood pressure

Trial Locations (1)

90301

Centinela Hospital Medical Center, Inglewood

All Listed Sponsors
collaborator

American College of Clinical Pharmacy

OTHER

lead

Western University of Health Sciences

OTHER

NCT00842023 - Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy | Biotech Hunter | Biotech Hunter